The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Managing Patients with Hyperchloremia

Nagami GT. Managing Patients with Hyperchloremia. Clin J Am Soc Nephrol. 2025 Jun 30. doi: 10.2215/CJN.0000000806. Epub ahead of print. PMID: 40587230.

Exploring Nanofiltration for Transport of Small Molecular Species for Application in Artificial Kidney Devices to Treat End-Stage Kidney Disease

Duncan H, Newton C, Hestekin J, Hestekin C, Kurtz I. Exploring Nanofiltration for Transport of Small Molecular Species for Application in Artificial Kidney Devices to[...]

Managing the failing renal allograft: navigating a complex topography

Kendrick EA. Managing the failing renal allograft: navigating a complex topography. Front Nephrol. 2025 Jun 5;4:1223114. doi: 10.3389/fneph.2024.1223114. PMID: 40538581; PMCID: PMC12176546.